Category - Feature

Feature

PureTech targeting dysfunctions in brain, gut, immune system

By Len Zehr With eight clinical-stage studies underway, including two pivotal trials expected to readout later this year, PureTech Health (LSE:PRTC) is taking a novel approach to drug development, targeting serious...

July 18, 2017

Feature

In conversation with John Gannon of TempTraq

By Len Zehr As president and CEO of closely-held Blue Spark Technologies and co-inventor of its newest product, TempTraq, John Gannon’s career has stretched from the aerospace industry to Wall Street, culminating in...

July 11, 2017

Feature

Klox focused on oral care launch, partner for wound care

By Len Zehr With franchises in dermatology, wound care and oral health, closely-held Klox Technologies has three near-term milestones this year: launching its oral care business with Colgate Palmolive; expanding the...

June 27, 2017

Feature

Canopy Health aims to evolve medical cannabis as a natural drug product and disrupt pharma market

By Len Zehr As president and CEO of newly formed Canopy Health Innovations, a spin off of Canopy Group (TSX:WEED), a world leading diversified cannabis company, Marc Wayne is a pioneer of the medical cannabis sector. He...

June 20, 2017

Feature

Medicure to leverage sales model to new products

By Len Zehr Medicure (TSXV:MPH) intends to leverage its unique sales and marketing model, which has fueled the growth of its Aggrastat IV platelet inhibitor, as it brings new generic products into its cardiovascular...

June 13, 2017

Feature

In conversation with Thomas Ronk of Buyins.net

By Len Zehr As the founder and CEO of Buyins.net, Thomas Ronk has created a proprietary database and trading strategy based on short sale timing and sales data that was not accessible to anyone prior to January 2005. As...

May 30, 2017

Feature

Microbix in talks with investors for Kinlytic relaunch

By Len Zehr Following a meeting with the FDA last month, Microbix Biosystems (TSX:MBX) is entertaining expressions of interest from potential partners to license or acquire its anti-clotting urokinase drug, which has...

May 23, 2017

Feature

IntelGenx has multi-faceted BD approach for its oral films

By Len Zehr With a burgeoning pipeline of pharmaceutical oral films, IntelGenx’s (OTCQX:IGXT; TSXV:IGX) business development strategy is focused on partnering its product pipeline along with actively meeting with...

May 16, 2017

Feature

3DS’ genomic imaging for precision medicine

By Len Zehr As CEO of 3D Signatures (OTCQB:TDSGF; TSXV:DXD; FSE:3D0) since last September, Jason Flowerday is putting the diagnostic company on people’s radar. Unlike most diagnostic companies, 3DS’ proprietary imaging...

May 2, 2017

Feature

Titan’s next ProNeura-based implant dovetails with PD awareness month

By Len Zehr After receiving FDA approval last year for its Probuphine implant as a maintenance treatment for opioid addiction, Titan Pharmaceuticals (NASDAQ:TTNP) is employing its ProNeura drug delivery technology to...

April 25, 2017

Category - Feature

Subscribe